|
|
Volumn 27, Issue 1, 2000, Pages 1-3
|
|
How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
RALOXIFENE;
RISEDRONIC ACID;
AGE;
AGED;
BONE DENSITY;
BONE TURNOVER;
EDITORIAL;
FEMALE;
FEMUR NECK FRACTURE;
FRACTURE REDUCTION;
HUMAN;
OSTEOPOROSIS;
POSTMENOPAUSE OSTEOPOROSIS;
RISK;
VERTEBRA FRACTURE;
AGED;
ALENDRONATE;
BONE AND BONES;
BONE DEMINERALIZATION, PATHOLOGIC;
ESTROGEN ANTAGONISTS;
FEMALE;
FRACTURES, BONE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
RALOXIFENE;
RISK;
|
|
EID: 0034080243
PISSN: 87563282
EISSN: None
Source Type: Journal
DOI: 10.1016/S8756-3282(00)00301-X Document Type: Editorial |
|
Times cited : (85)
|
|
References (26)
|
